RSS

Archivi categoria: farmacoeconomia

PD Versus HD: Do I Have a Choice? – AJKD Blog

Sorgente: PD Versus HD: Do I Have a Choice? – AJKD Blog

atients with advanced chronic kidney disease (CKD) and their families fear dialysis, and the selection of a renal replacement therapy (RRT) is not easy. It is uncertain how much patients with CKD must understand about their disease process and treatment options before they can make an informed decision. Are there psychosocial elements that influence the decision of which RRT modality is “right”? Are we providing the necessary information so patients can make their decision appropriately?

 

Antibiotic-Associated Adverse Events Common

Sorgente: Antibiotic-Associated Adverse Events Common

 
Lascia un commento

Pubblicato da su 23 giugno 2017 in appopriatezza, farmaci, farmacoeconomia

 

The Waiting Game — Why Providers May Fail to Reduce Wait Times — NEJM – Problemi  dalle liste di attesa

Sorgente: The Waiting Game — Why Providers May Fail to Reduce Wait Times — NEJM

 

2_Rapporto_GIMBE_Sostenibilita_SSN.pdf

Sorgente: 2_Rapporto_GIMBE_Sostenibilita_SSN.pdf

 

Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD – American Journal of Kidney Diseases

Sorgente: Cost-effectiveness Analysis of Vascular Access Referral Policies in CKD – American Journal of Kidney Diseases

 

SG_male_alle_ginocchia.pdf

Sorgente: SG_male_alle_ginocchia.pdf

 

Quanti italiani rinunciano davvero alle cure? | Scienza in Rete

Sorgente: Quanti italiani rinunciano davvero alle cure? | Scienza in Rete

 
 
%d blogger hanno fatto clic su Mi Piace per questo: